Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ / shares in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Net revenues	$ 805,126	$ 739,538	$ 2,592,738	$ 2,351,201
Cost of sales	487,055	506,562	1,427,512	1,143,600
Gross Profit	318,071	232,976	1,165,226	1,207,601
Operating expenses:
Research and development	169,650	115,202	464,167	331,785
Selling, general and administrative	208,639	332,190	724,729	975,584
Depreciation and amortization	5,506	5,506	16,517	16,603
Total operating expenses	383,795	452,898	1,205,413	1,323,972
(Loss) from operations	(65,724)	(219,922)	(40,187)	(116,371)
Other income (expense):
Interest income	6,051	6,846	19,745	20,292
Interest and finance expenses	(857)	(838)	(3,728)	(2,811)
Total other income (expense)	5,194	6,008	16,017	17,481
(Loss) before provision for income taxes	(60,530)	(213,914)	(24,170)	(98,890)
Provision (benefit) for income taxes:
Current	(12,985)	(6,000)	(11,985)
Deferred	72,000	(65,000)	82,000	(97,000)
Total provision (benefit) for income taxes	59,015	(71,000)	70,015	(97,000)
Net (loss)	$ (119,545)	$ (142,914)	$ (94,185)	$ (1,890)
Basic and diluted per common share: (in dollars per share)	$ 0	$ 0	$ 0	$ 0
Weighted average shares of common stock outstanding - basic and diluted (in shares)	67,588,492	67,588,492	67,588,492	67,588,492